Analgesia After Cesarean Section
Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.
|Study Design:||Observational Model: Case Control
Time Perspective: Retrospective
- Change of numeric rating scale (NRS) of postoperative pain during postoperative period [ Time Frame: postoperative 1, 2, 3, and 4 day ] [ Designated as safety issue: No ]
- incidence of stopping of intravenous PCA during postoperative 4 days [ Time Frame: during postoperative 4 days ] [ Designated as safety issue: No ]
- serum magnesium level of group P [ Time Frame: preoperative 1 h and postoperative 1 day ] [ Designated as safety issue: No ]
|Study Start Date:||December 2010|
|Study Completion Date:||March 2011|
|Primary Completion Date:||March 2011 (Final data collection date for primary outcome measure)|
parturients who had undergone Cesarean section under the diagnosis of non-preeclampsia
parturients who had undergone Cesarean section under the diagnosis of preeclampsia
Drug: Magnesium Sulphate
Magnesium sulphate was infused for the management of preeclampsia at perioperative period.